GIACOBBE, DANIELE ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 21.087
AS - Asia 3.986
NA - Nord America 3.446
Continente sconosciuto - Info sul continente non disponibili 739
SA - Sud America 326
AF - Africa 80
OC - Oceania 11
Totale 29.675
Nazione #
IT - Italia 20.477
US - Stati Uniti d'America 3.231
SG - Singapore 1.357
CN - Cina 885
VN - Vietnam 691
BD - Bangladesh 644
FR - Francia 204
BR - Brasile 179
HK - Hong Kong 121
CA - Canada 93
DE - Germania 91
FI - Finlandia 55
GB - Regno Unito 49
AR - Argentina 46
JP - Giappone 44
NL - Olanda 44
IQ - Iraq 37
IN - India 36
MX - Messico 30
ES - Italia 27
JM - Giamaica 26
EC - Ecuador 23
ID - Indonesia 23
CO - Colombia 21
CR - Costa Rica 19
ZA - Sudafrica 19
PH - Filippine 17
TR - Turchia 16
VE - Venezuela 16
SE - Svezia 14
JO - Giordania 13
PK - Pakistan 12
PY - Paraguay 12
RU - Federazione Russa 12
PL - Polonia 11
UA - Ucraina 11
AU - Australia 10
PE - Perù 10
TH - Thailandia 10
CH - Svizzera 9
CL - Cile 9
EG - Egitto 9
HN - Honduras 9
IE - Irlanda 9
NP - Nepal 9
UZ - Uzbekistan 9
DZ - Algeria 8
ET - Etiopia 8
MA - Marocco 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
KR - Corea 7
TT - Trinidad e Tobago 7
AT - Austria 6
MY - Malesia 6
PT - Portogallo 6
RS - Serbia 6
TN - Tunisia 6
UY - Uruguay 6
BE - Belgio 5
HU - Ungheria 5
KE - Kenya 5
PR - Porto Rico 5
RO - Romania 5
SV - El Salvador 5
BB - Barbados 4
BG - Bulgaria 4
BO - Bolivia 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HR - Croazia 4
KZ - Kazakistan 4
LB - Libano 4
MK - Macedonia 4
NI - Nicaragua 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
GA - Gabon 3
IL - Israele 3
MT - Malta 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BY - Bielorussia 2
GT - Guatemala 2
KG - Kirghizistan 2
KY - Cayman, isole 2
LT - Lituania 2
MD - Moldavia 2
PS - Palestinian Territory 2
SC - Seychelles 2
SI - Slovenia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BH - Bahrain 1
Totale 28.920
Città #
Genoa 8.583
Genova 6.926
Vado Ligure 2.159
Rapallo 2.009
San Jose 704
Singapore 691
Ashburn 440
Ho Chi Minh City 216
New York 183
Lauterbourg 175
Council Bluffs 168
Beijing 166
Hanoi 166
Hong Kong 118
Santa Clara 93
Los Angeles 89
Bordighera 78
Rome 73
Milan 72
Frankfurt am Main 65
Buffalo 51
Helsinki 51
Tokyo 39
Chicago 37
Haiphong 34
Naples 32
Dallas 31
Da Nang 28
Houston 27
Atlanta 26
Boardman 26
Toronto 22
Bologna 20
Orem 20
Phoenix 19
The Bronx 19
Amsterdam 18
Biên Hòa 17
San Francisco 17
São Paulo 17
Florence 16
San José 16
Brooklyn 15
Montreal 15
Baghdad 14
Kansas City 14
Tianjin 14
Amman 13
City of London 13
Guangzhou 13
London 13
Madrid 12
Austin 11
Bari 11
Denver 11
Johannesburg 11
Quito 11
Stockholm 11
Turin 11
Verona 11
Kingston 10
Las Vegas 10
Mexico City 10
Miami 10
Modena 10
Paris 10
Charlotte 9
Columbus 9
Hải Dương 9
Lima 9
Orlando 9
Philadelphia 9
Tashkent 9
Thái Nguyên 9
Zurich 9
Addis Ababa 8
Can Tho 8
Chennai 8
Dhaka 8
Fort Wayne 8
Padua 8
Queens 8
Seattle 8
Venice 8
Warsaw 8
Asunción 7
Bangkok 7
Catania 7
Curitiba 7
Istanbul 7
Jakarta 7
Kyiv 7
Belgrade 6
Berlin 6
Cagliari 6
Dublin 6
Marseille 6
Milwaukee 6
Nashville 6
Newark 6
Totale 24.299
Nome #
Artificial intelligence and prescription of antibiotic therapy: present and future 426
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 344
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 278
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 245
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 244
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 234
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 234
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 230
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 230
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area 228
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 224
Mould Infections of Traumatic Wounds: A Brief Narrative Review 215
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 212
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 208
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 202
Use of colistin in adult patients: a cross-sectional study 202
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 198
Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis 197
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 196
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 193
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 191
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 189
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 186
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 186
Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population 186
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals 186
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 182
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 181
Bloodstream infections in critically ill patients with COVID-19 180
Management of KPC-producing Klebsiella pneumoniae infections 179
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 178
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 178
Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy 178
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 177
Aortic cross-clamp time and cardiopulmonary bypass time: prognostic implications in patients operated on for infective endocarditis 177
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 174
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 174
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 172
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 172
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 168
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 167
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A 8-year retrospective study in a large teaching hospital in northern Italy 165
Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis 163
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic 161
Will new antimicrobials overcome resistance among Gram-negatives? 159
Current pharmacotherapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia 159
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 158
Treatment of Infections Due to MDR Gram-Negative Bacteria 156
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery 154
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes 154
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 153
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 152
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 151
Impact of negative blood cultures on outcome after surgery for acute infective endocarditis 151
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 150
Towards the automatic calculation of the EQUAL Candida Score: Extraction of CVC-related information from EMRs of critically ill patients with candidemia in Intensive Care Units 150
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 148
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 148
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 146
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 145
A look at clinical trial design for new antimicrobials for the adult population 142
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 141
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis 141
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 141
Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review 141
Isolation of Candida auris from invasive and noninvasive samples of a patient suffering from vascular disease, Italy, July 2019 141
Bloodstream infections in internal medicine 140
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 140
The role of fosfomycin for multidrug-resistant gram-negative infections 140
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae 139
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 136
Culture-negative infective endocarditis (CNIE): impact on postoperative mortality 135
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 134
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 134
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 134
History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies 133
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 132
A wide database for future studies aimed at improving early recognition of candidemia 128
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 128
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 126
Ceftolozane/tazobactam: place in therapy 126
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 126
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 125
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 125
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study 125
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 124
A NLP Pipeline for the Automatic Extraction of a Complete Microorganism’s Picture from Microbiological Notes 124
Risk factors andmortality of healthcare-associated and community-acquired Staphylococcus aureusbacteraemia 124
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 124
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 124
Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment 122
Valutazione dei fattori di rischio per lo sviluppo di candidemia dopo interventi di cardiochirurgia maggiore 121
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 119
Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit 118
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 118
New insights into infections due to multidrug resistant gram negative bacteria: The interplay between lab and clinic 117
Factors associated with lack of viral suppression at delivery 117
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 117
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 116
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study 114
Totale 16.576
Categoria #
all - tutte 111.985
article - articoli 108.938
book - libri 0
conference - conferenze 1.336
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.354
Totale 223.613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.858 72 52 93 182 87 134 68 357 223 194 108 288
2022/20232.468 222 207 31 232 294 324 85 161 400 145 303 64
2023/20241.690 80 187 45 216 150 252 142 112 83 77 127 219
2024/20255.696 152 358 157 386 784 580 548 928 240 284 546 733
2025/202611.478 1.262 458 914 727 1.161 637 1.448 666 985 1.079 945 1.196
2026/20271.001 1.001 0 0 0 0 0 0 0 0 0 0 0
Totale 29.675